Walgreens is lowering the price it will pay to buy drugstore rival Rite Aid and raising the number of stores it will unload to ease monopoly concerns.
Continue Reading Below
The companies initially planned to sell no more than 500 stores, but that was pushed to 1,200 Monday.
Walgreens will now spend between $6.50 to $7 per share of shares of Rite Aid, depending on how many stores they need to divest. Walgreens originally planned to pay $9 per share for the nation's third-largest drugstore chain in a roughly $9.4 billion deal announced in the fall of 2015.
The deadline to complete the deal, which expired last week, was extended to the end of July.
Shares of Rite Aid Corp. tumbled 16 percent to $5.81, while Walgreens Boots Alliance Inc. are up slightly.